舌下神经刺激与心率变异性:STAR试验应答者分析
本研究为STAR试验子研究,纳入46例应答者,术后12个月随机分为继续治疗或撤除治疗,分析舌下神经刺激对心率变异性的影响。结果显示SDNN与低频功率从基线至12个月在全部睡眠期显著改善,SDNN降低与AHI改善相关(r=0.39,P=.03),撤除治疗1周未影响该变化。
要点
- 舌下神经刺激可降低睡眠期心率变异性,提示自主神经功能改善
- SDNN降低与呼吸暂停低通气指数改善相关(r=0.39,P=.03)
- 撤除治疗1周未显著改变N1/N2、N3及REM期SDNN
核心结论
- 舌下神经刺激治疗似可降低睡眠期心率变异性,且该降低未受1周撤除治疗影响,仍需更大样本前瞻性研究验证其对自主神经功能障碍的作用。
研究设计与样本
- STAR试验(刺激治疗减少呼吸暂停)子研究,多中心前瞻性单组队列,受试者为美国与欧洲学术及私人执业中心参与者。
- 应答者子集n=46,于术后12个月随机分为治疗撤除组或治疗维持组。
主要发现
- 从基线至12个月,SDNN与低频功率在全部睡眠期均显著改善。
- SDNN在清醒期无变化(均值±标准差:0.042±0.01 vs 0.077±0.07,P=.19)。
- SDNN降低与呼吸暂停低通气指数改善相关(r=0.39,P=.03)。
- 撤除治疗组N1/N2、N3及快速眼动睡眠期SDNN未见显著变化。
关键数值与推荐
- 心率变异性分析指标包括R-R间期标准差(SDNN)、R-R间期低频功率与高频功率。
- 分析按睡眠期进行,采用5分钟滑动窗口,时间点为基线、12个月及维持/撤除期。
临床怎么用
- 对植入舌下神经刺激的中重度阻塞性睡眠呼吸暂停应答者,可关注睡眠期心率变异性改善作为自主神经获益的参考。
- 短期撤除治疗1周内睡眠期SDNN未见显著变化,解读心率变异性指标时需考虑此特点。
局限性
- 为STAR试验子研究,仅分析应答者子集(n=46),样本量有限。
- 作者指出需更大规模前瞻性研究以更好理解舌下神经刺激对阻塞性睡眠呼吸暂停自主神经功能障碍的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Hypoglossal nerve stimulation represents a novel therapy for the treatment of moderate-severe obstructive sleep apnea; nonetheless, its cardiovascular effects are not known. We examine the effects of hypoglossal nerve stimulation on heart rate variability, a measure of autonomic function. STUDY DESIGN: Substudy of the STAR trial (Stimulation Therapy for Apnea Reduction): a multicenter prospective single-group cohort. SETTING: Academic and private practice centers in the United States and Europe. SUBJECTS AND METHODS: A subset of responder participants (n = 46) from the STAR trial was randomized to therapy withdrawal or therapy maintenance 12 months after surgery. Heart rate variability analysis included standard deviation of the R-R interval (SDNN), low-frequency power of the R-R interval, and high-frequency power of the R-R interval. Analysis was performed by sleep with 5-minute sliding window epochs during baseline, 12 months, and the maintenance/withdrawal period. RESULTS: A significant improvement from baseline to 12 months in heart rate variability was seen for SDNN and low frequency across all sleep stages. SDNN analysis demonstrated no change in the wake period (mean ± SD: 0.042 ± 0.01 vs 0.077 ± 0.07, P = .19). Reduction in SDNN was correlated to improvement in apnea-hypopnea index ( r = 0.39, P = .03). In the therapy withdrawal group, no significant changes in SDNN were seen for N1/N2, N3, or rapid eye movement sleep. CONCLUSION: Hypoglossal nerve stimulation therapy appears to reduce heart rate variability during sleep. This reduction was not affected by a 1-week withdrawal period. Larger prospective studies are required to better understand the effect of hypoglossal nerve stimulation on autonomic dysfunction in obstructive sleep apnea.
引用
- Dedhia RC, Shah AJ, Bliwise DL, et al. Hypoglossal Nerve Stimulation and Heart Rate Variability: Analysis of STAR Trial Responders. Otolaryngol Head Neck Surg. 2018. PMID: 30223721. doi:10.1177/0194599818800284
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。